Iovance Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 27.78 M | $92.50 M | 0.88% | 8.60% |
| MHR FUND MANAGEMENT LLC | 05/15/2025 | 24.42 M | $81.31 M | 0.00% | 7.56% |
| BLACKROCK, INC. | 05/02/2025 | 24.31 M | $80.97 M | 3.57% | 7.53% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 12.71 M | $42.33 M | -42.51% | 3.94% |
| STATE STREET CORP | 05/15/2025 | 11.04 M | $36.77 M | -9.86% | 3.42% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 05/15/2025 | 9.25 M | $30.80 M | 80.24% | 2.87% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 9.22 M | $30.69 M | 2.50% | 2.85% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 7.79 M | $25.92 M | 18.67% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 5.97 M | $19.88 M | 1.65% | 1.85% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 5.78 M | $19.24 M | 202.84% | 1.79% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 5.57 M | $18.55 M | 35.57% | 1.73% |
| INVENOMIC CAPITAL MANAGEMENT LP | 05/15/2025 | 5.49 M | $18.28 M | 100.00% | 1.70% |
| MACQUARIE GROUP LTD | 05/15/2025 | 4.79 M | $15.96 M | 0.85% | 1.48% |
| PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 4.69 M | $15.63 M | 28.72% | 1.45% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 4.41 M | $14.68 M | -2.96% | 1.37% |
| MORGAN STANLEY | 05/15/2025 | 4.02 M | $13.38 M | 1.48% | 1.24% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 3.51 M | $11.69 M | 100.00% | 1.09% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 3.51 M | $11.68 M | 44.27% | 1.09% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 3.21 M | $10.69 M | 5.58% | 0.99% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 3.02 M | $10.05 M | 306.95% | 0.93% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 2.71 M | $9.02 M | 1.30% | 0.84% |
| UBS GROUP AG | 05/13/2025 | 2.50 M | $8.31 M | -7.68% | 0.77% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 2.40 M | $8.01 M | -8.52% | 0.74% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.40 M | $7.99 M | 69.49% | 0.74% |
| NORTHERN TRUST CORP | 05/13/2025 | 2.34 M | $7.80 M | -2.95% | 0.73% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 1.93 M | $6.43 M | -66.92% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.85 M | $6.15 M | -7.12% | 0.57% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 1.80 M | $6.00 M | -32.32% | 0.56% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.80 M | $5.99 M | 260.00% | 0.56% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.73 M | $5.77 M | 58.45% | 0.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 1.57 M | $5.23 M | -1.59% | 0.49% |
| 05/15/2025 | 1.50 M | $5.00 M | 51.21% | 0.46% | |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.28 M | $4.26 M | -2.03% | 0.40% |
| APIS CAPITAL ADVISORS, LLC | 05/15/2025 | 1.28 M | $4.25 M | -6.31% | 0.40% |
| C WORLDWIDE GROUP HOLDING A/S | 05/05/2025 | 1.26 M | $4.20 M | 0.00% | 0.39% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 1.26 M | $4.19 M | 100.00% | 0.39% |
| ORION INVESTMENT CO | 05/14/2025 | 1.18 M | $3.92 M | 10.94% | 0.36% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 1.17 M | $3.90 M | 100.00% | 0.36% |
| NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 1.12 M | $3.73 M | 0.00% | 0.35% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 972.69 K | $3.24 M | 100.00% | 0.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 920.46 K | $3.27 M | 10.76% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 918.21 K | $3.06 M | 6.05% | 0.28% |
| 05/12/2025 | 886.74 K | $2.95 M | 100.00% | 0.27% | |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 858.57 K | $2.86 M | 47.97% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 832.30 K | $2.77 M | -58.96% | 0.26% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 685.15 K | $2.28 M | -21.03% | 0.21% |
| QVT FINANCIAL LP | 05/15/2025 | 678.56 K | $2.26 M | 0.00% | 0.21% |
| CITADEL ADVISORS LLC | 05/15/2025 | 675.00 K | $2.25 M | -32.29% | 0.21% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2025 | 647.83 K | $2.16 M | -47.56% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 623.10 K | $2.07 M | 44.04% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iovance Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 389 institutional investors and hedge funds held shares of Iovance Biotherapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 27.78 M
MHR FUND MANAGEMENT LLC: 24.42 M
BlackRock, Inc.: 24.31 M
PERCEPTIVE ADVISORS LLC: 12.71 M
STATE STREET CORP: 11.04 M
Long Focus Capital Management, LLC: 9.25 M
74.16% of Iovance Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 272.51 M shares in the last 24 months. This purchase volume represents approximately $564.09 M in transactions.